[ad_1] The obesity drugs that powered huge investor gains in 2023 are poised to inspire…
Tag:
development
-
-
STOCK MARKET
Sanofi suffers major blow as its cutting-edge cancer drug disappoints in Phase III trials
by userby user[ad_1] French pharmaceuticals giant Sanofi SAN, -0.44% on Thursday said it would be halting development…
-
STOCK MARKET
Seven tech stocks that can broaden your exposure beyond the “Magnificent Seven”
by userby user[ad_1] During the bull market of 2023, the “Magnificent Seven” stocks have dominated financial media…
-
[ad_1] Moderna Inc.’s stock soared 14% early Thursday after the biotech company and partner Merck…
-
STOCK MARKET
Vertex’s stock heads for all-time high as non-opioid painkiller shows promise
by userby user[ad_1] Vertex Pharmaceuticals Inc. shares VRTX, +11.10% were on track for an all-time high Wednesday…
-
STOCK MARKET
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
by userby user[ad_1] Crispr Therapeutics AG CRSP, -5.33% and Vertex Pharmaceuticals Inc. VRTX, -0.82% on Friday got…
-
STOCK MARKET
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
by userby user[ad_1] Roche has agreed to buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion,…
-
STOCK MARKET
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
by userby user[ad_1] Pfizer Inc.’s stock tumbled 4% premarket Friday, after the company said it would not…
-
[ad_1] Amazon.com Inc. AMZN is launching a program that aims to train millions of workers…
-
STOCK MARKET
Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted
by userby user[ad_1] Bayer lost a fifth of its market value at one point Monday, after the…